Reliance Life Sciences Pvt. Ltd. operates as a life sciences company. Its activities include researching, developing, and marketing plasma proteins, biosimilars, and proteins; developing active pharmaceutical ingredients and formulations, such as oncology products, steroids, hormones, and peptides; offering services, which include regulatory toxicity studies, bioavailability, pharmacokinetics, cardiac safety, mass balance studies, phase I to IV clinical trial management and monitoring, data management and biostatistics, and medical writing; and providing regenerative medicine, which include embryonic stem cells, ocular stem cells, haematopoietic stem cells, skin and tissue engineering, and a...
Dhirubhai Ambani Life Sciences Centre
R-282, TTC Area of MIDC
Navi Mumbai, 400 701
Founded in 2001
91 22 6767 8000
91 22 6767 8099
Delhi High Court Places Temporary Injunction Preventing Sales of Reliance's Biosimilar Trastuzumab
Nov 4 15
The Indian Delhi High Court has issued a temporary injunction banning Reliance (India) from launching a "biosimilar" version of Roche (Switzerland)'s breast cancer drug Herceptin (trastuzumab). The injunction follows a petition filed by Roche, which argues that Reliance's product is similar to Herceptin. The two companies have now been requested to submit written submissions within two weeks before the court is to hear the case.
Torrent Pharmaceuticals Ltd Enters into an Exclusive Licensing Agreement with Reliance Life Sciences
Dec 26 14
Torrent Pharmaceuticals Ltd. has entered into an exclusive licensing agreement with Reliance Life Sciences for marketing three biosimilars in the Indian market. Torrent Pharmaceuticals informed that Rituximab, Adalimumab and Cetuximab will be developed by Reliance Life Sciences and supplied to Torrent Pharma after obtaining all necessary regulatory approvals. Torrent Pharma will be the only company to market these biosimilars in India other than Reliance Life Sciences. According to the terms of agreement, Reliance Life Sciences will manufacture these products at its facility in Navi Mumbai and supply to Torrent Pharma for 10 years.